The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

NCT00171314 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

527

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Zoledronic acid
DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals